Cover Image

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone

Show other versions (1)

Saved in:

Bibliographic Details
Main Author:	Ross M. Colquhoun (Author)
Format:	Book
Published:	SAGE Publishing, 2013-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
by: Ross M. Colquhoun
Published: (2013)

Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021)

Low Dose Naltrexone - Efficacy and safety of off-label use therapy.
by: Andrzej Stańczak
Published: (2020)

Naltrexone-induced acute generalized exanthematous pustulosis
by: Jason Eakes, BS, et al.
Published: (2023)

Effects of genotype and food on naltrexone exposure in adolescents
by: Stephani L. Stancil, et al.
Published: (2022)

The importance of dosage for naltrexone treatment in Hailey-Hailey disease
by: Chloé Grolleau, MD, MSc, et al.
Published: (2022)

Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023)

Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment
by: Kristine A.U. Pallesen, et al.
Published: (2019)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
by: Peindl K, et al.
Published: (2011)

Naltrexone extended-release injection: an option for the management of opioid abuse
by: Taylor Jr R, et al.
Published: (2011)

Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011)

Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program
by: Reece AS
Published: (2007)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
by: Laura M. Szczesniak, et al.
Published: (2020)

Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis
by: O. V. Golianovskyi, et al.
Published: (2020)

Naltrexone Protects Against Lipopolysaccharide/D-Galactosamine-Induced Hepatitis in Mice
by: Chien-Chuan Wang, et al.
Published: (2008)

Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone
by: Aimee N. Jensen, PharmD, BCPS, BCPP, et al.
Published: (2021)

Naltrexone blockade of OGFr enhances cutaneous wound closure in diabetic rats
by: Patricia J. McLaughlin, et al.
Published: (2021)

Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
by: Milne Brian, et al.
Published: (2010)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus
by: Lauren C. LaMonica, MPH, et al.
Published: (2023)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
by: Negin Farhadian, et al.
Published: (2020)

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
by: Xuechan Lyu, et al.
Published: (2018)

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study
by: Almasa Bass, et al.
Published: (2019)

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Caixàs A, et al.
Published: (2014)

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide
by: Goli Veeraindar, et al.
Published: (2012)

Naltrexone Protects Against Hypotension, Hyperthermia, and β-Endorphin Overproduction During Heatstroke in the Rat
by: Yi-Ping Huang, et al.
Published: (2005)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020)

Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study
by: Lyu YS, et al.
Published: (2024)

Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery
by: Abayomi T. Ogunjimi, et al.
Published: (2020)

Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications
by: Elena R. Beauregard, PharmD, BCPS, et al.
Published: (2024)

Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Buehler AM
Published: (2015)

Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine
by: Sherif A. Abdel-Gawad, et al.
Published: (2018)

Comparison of General Well-being of Patients Undergoing Methadone Maintenance Therapy (MMT) with Patients Undergoing Naltrexone Therapy.
by: Mehdi Sayyah, et al.
Published: (2013)

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
by: Albert Stuart Reece
Published: (2012)

Low-dose naltrexone-induced remission in Hailey-Hailey disease maintained in remission with topical combination of ketamine and diphenhydramine
by: Sidharth Sonthalia, et al.
Published: (2019)

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
by: Albert Stuart Reece
Published: (2012)

Naltrexone-Induced Cardiac Function Improvement is Associated With an Attenuated Inflammatory Response and Lipid Perioxidation in Volume Overloaded Rats
by: Lukas Dehe, et al.
Published: (2022)

Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD
by: Michele Staton, et al.
Published: (2021)

Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder
by: Babajide Shenkoya, et al.
Published: (2024)

Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin
by: James H. Ford, et al.
Published: (2019)